Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Duverger

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Clinical Science (London, England : 1979)|February 27, 2001
Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-I with severe hypercholesterolaemiaA Boullier, N Hennuyer, A Tailleux, et al.
The Journal of Clinical Investigation|January 1, 1994
Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye diseaseD J Rader, K Ikewaki, N Duverger, et al.
Circulation|May 11, 1999
Beneficial effects of fibrates on apolipoprotein A-I metabolism occur independently of any peroxisome proliferative responseN Hennuyer, P Poulain, L Madsen, et al.
Journal of Lipid Research|February 13, 2001
Three arginine residues in apolipoprotein A-I are critical for activation of lecithin:cholesterol acyltransferaseS Roosbeek, B Vanloo, N Duverger, et al.
The Journal of Clinical Investigation|June 1, 1996
Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic miceL Berthou, N Duverger, F Emmanuel, et al.
Biochemical and Biophysical Research Communications|February 12, 1998
Endothelial derived vasorelaxation is impaired in human APO A-I transgenic rabbitsG Lebuffe, A Boullier, A Tailleux, et al.
Circulation Research|September 16, 2000
Antiangiogenic effect of interleukin-10 in ischemia-induced angiogenesis in mice hindlimbJ S Silvestre, Z Mallat, M Duriez, et al.
Journal of Lipid Research|April 6, 2001
Effect of mutations of N- and C-terminal charged residues on the activity of LCATF Peelman, B Vanloo, J L Verschelde, et al.
Circulation|December 16, 1998
Severe atherosclerosis and hypoalphalipoproteinemia in the staggerer mouse, a mutant of the nuclear receptor RORalphaA Mamontova, S Séguret-Macé, B Esposito, et al.
The Journal of Biological Chemistry|February 14, 1998
Apolipoprotein(a) yeast artificial chromosome transgenic rabbits. Lipoprotein(a) assembly with human and rabbit apolipoprotein BD Rouy, N Duverger, S D Lin, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Clinical Science (London, England : 1979)|February 27, 2001
Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-I with severe hypercholesterolaemiaA Boullier, N Hennuyer, A Tailleux, et al.
The Journal of Clinical Investigation|January 1, 1994
Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye diseaseD J Rader, K Ikewaki, N Duverger, et al.
Circulation|May 11, 1999
Beneficial effects of fibrates on apolipoprotein A-I metabolism occur independently of any peroxisome proliferative responseN Hennuyer, P Poulain, L Madsen, et al.
Journal of Lipid Research|February 13, 2001
Three arginine residues in apolipoprotein A-I are critical for activation of lecithin:cholesterol acyltransferaseS Roosbeek, B Vanloo, N Duverger, et al.
The Journal of Clinical Investigation|June 1, 1996
Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic miceL Berthou, N Duverger, F Emmanuel, et al.
Biochemical and Biophysical Research Communications|February 12, 1998
Endothelial derived vasorelaxation is impaired in human APO A-I transgenic rabbitsG Lebuffe, A Boullier, A Tailleux, et al.
Circulation Research|September 16, 2000
Antiangiogenic effect of interleukin-10 in ischemia-induced angiogenesis in mice hindlimbJ S Silvestre, Z Mallat, M Duriez, et al.
Journal of Lipid Research|April 6, 2001
Effect of mutations of N- and C-terminal charged residues on the activity of LCATF Peelman, B Vanloo, J L Verschelde, et al.
Circulation|December 16, 1998
Severe atherosclerosis and hypoalphalipoproteinemia in the staggerer mouse, a mutant of the nuclear receptor RORalphaA Mamontova, S Séguret-Macé, B Esposito, et al.
The Journal of Biological Chemistry|February 14, 1998
Apolipoprotein(a) yeast artificial chromosome transgenic rabbits. Lipoprotein(a) assembly with human and rabbit apolipoprotein BD Rouy, N Duverger, S D Lin, et al.
Pageof 6